ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 82 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2014. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,004,200 | -22.6% | 48,764 | -12.1% | 0.01% | +12.5% |
Q1 2024 | $2,590,595 | -16.7% | 55,485 | -14.7% | 0.01% | -20.0% |
Q4 2023 | $3,111,552 | +27.7% | 65,068 | -4.8% | 0.01% | +11.1% |
Q3 2023 | $2,436,214 | +5.0% | 68,337 | +35.9% | 0.01% | +12.5% |
Q2 2023 | $2,319,970 | +15.0% | 50,292 | 0.0% | 0.01% | +14.3% |
Q1 2023 | $2,016,709 | -35.4% | 50,292 | -25.3% | 0.01% | -41.7% |
Q4 2022 | $3,119,909 | +59.3% | 67,341 | +42.4% | 0.01% | +50.0% |
Q3 2022 | $1,958,000 | -30.6% | 47,289 | 0.0% | 0.01% | -27.3% |
Q2 2022 | $2,821,000 | -12.4% | 47,289 | +6.7% | 0.01% | +10.0% |
Q1 2022 | $3,220,000 | -9.4% | 44,338 | +4.9% | 0.01% | 0.0% |
Q4 2021 | $3,556,000 | -6.4% | 42,284 | +0.4% | 0.01% | -16.7% |
Q3 2021 | $3,800,000 | +0.7% | 42,132 | +6.5% | 0.01% | 0.0% |
Q2 2021 | $3,773,000 | -13.6% | 39,570 | +3.2% | 0.01% | -20.0% |
Q1 2021 | $4,368,000 | -17.1% | 38,360 | +0.8% | 0.02% | -21.1% |
Q4 2020 | $5,268,000 | +57.9% | 38,055 | -6.3% | 0.02% | +46.2% |
Q3 2020 | $3,337,000 | +3.8% | 40,604 | -1.2% | 0.01% | 0.0% |
Q2 2020 | $3,215,000 | +22.8% | 41,096 | -30.3% | 0.01% | 0.0% |
Q1 2020 | $2,619,000 | +4.1% | 58,944 | 0.0% | 0.01% | +44.4% |
Q4 2019 | $2,517,000 | +28.5% | 58,944 | +28.7% | 0.01% | +12.5% |
Q3 2019 | $1,959,000 | +228.1% | 45,800 | +387.2% | 0.01% | +300.0% |
Q2 2019 | $597,000 | -8.4% | 9,400 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $652,000 | +59.4% | 9,400 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $409,000 | -43.0% | 9,400 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $718,000 | -0.7% | 9,400 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $723,000 | +50.9% | 9,400 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $479,000 | +9.9% | 9,400 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $436,000 | -13.0% | 9,400 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $501,000 | -14.2% | 9,400 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $584,000 | -8.3% | 9,400 | 0.0% | 0.00% | -33.3% |
Q1 2017 | $637,000 | -3.6% | 9,400 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $661,000 | -0.9% | 9,400 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $667,000 | +45.0% | 9,400 | 0.0% | 0.00% | +50.0% |
Q2 2016 | $460,000 | -22.7% | 9,400 | 0.0% | 0.00% | -33.3% |
Q1 2016 | $595,000 | -71.8% | 9,400 | -50.0% | 0.00% | -25.0% |
Q4 2015 | $2,108,000 | +132.9% | 18,800 | +100.0% | 0.00% | 0.0% |
Q3 2015 | $905,000 | -5.9% | 9,400 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $962,000 | +64.7% | 9,400 | 0.0% | 0.00% | +100.0% |
Q1 2015 | $584,000 | +41.7% | 9,400 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $412,000 | -22.6% | 9,400 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $532,000 | +26.1% | 9,400 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $422,000 | – | 9,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |